Impel NeuroPharma Completes Industry's First Nose-to-Brain Human Imaging Study

... of CNS conditions that currently lack a good treatment option," Hite added. Dr. William Frey II, Director of the Alzheimer's Research Center and Professor of Pharmaceutics, Neurology and Neuroscience at the University of Minnesota commented, "Since ...

http://technews.tmcnet.com/news/2013/04/18/7072350.htm